<DOC>
	<DOCNO>NCT03106792</DOCNO>
	<brief_summary>The primary outcome study effect Hairfinity v . Placebo rate distal hair growth , assess use Trichoscan HD , healthy female adult baseline day 90 ( end study ) .</brief_summary>
	<brief_title>A Clinical Trial Evaluate Effectiveness Hairfinity Improving Hair Health Rate Growth</brief_title>
	<detailed_description />
	<criteria>1 . Female 1850 year age ( inclusive ) 2 . Subject child bear potential . Defined female hysterectomy oophorectomy , bilateral tubal ligation postmenopausal ( natural surgically &gt; 1 year since last menstruation ) . OR Female subject childbearing potential must agree use medically approve method birth control negative urine pregnancy test result . Acceptable method birth control include : Hormonal contraceptive include oral contraceptive , hormone birth control patch ( Ortho Evra ) , vaginal contraceptive ring ( NuvaRing ) , injectable contraceptive ( DepoProvera , Lunelle ) , hormone implant ( Norplant System ) Intrauterine device Vasectomy partner Double Barrier Method Nonheterosexual lifestyle 3 . Fitzpatrick skin type IV ( See appendix 3 ) 4 . Willing maintain colour style hair cut duration study 5 . Willing maintain shampooing frequency general hair regime duration study 6 . Willing cut hair duration study 7 . Willing area hair prepped Trichoscan analysis 8 . Healthy determine laboratory result , medical history , physical exam 9 . Subjects must agree comply study procedures 10 . Has give voluntary , write , inform consent participate study 1 . Women pregnant , breastfeeding , plan become pregnant course trial . 2 . Women begin hormonal birth control hormone replacement within 6 month randomization 3 . Subjects take natural health product , include multivitamin , botanical nutraceuticals , within 2 week randomization duration study 4 . Subjects Fitzpatrick score V , stem sensitivity test method ( require degree color contrast evaluate hair relative skin ) 5 . Subjects underwent form treatment thin hair , include prescription drug light therapy within 6 month randomization 6 . Medical history diagnose alopecia and/or trichotillomania ( compulsive hair pull ) . Medical history may assess Qualified Investigator 7 . Subjects currently use hair extension 8 . Subjects psoriasis active dermatological condition scalp randomization opinion qualify investigator would interfere clinical evaluation 9 . Medical history thyroid disorder TSH level outside normal range ( 0.44.5 Â±0.05 ) assess Qualified Investigator 10 . Unstable medical condition determine qualified investigator 11 . Clinically significant abnormal lab result screen assessed Qualified Investigator 12 . History , current diagnosis cancer ( except successfully treat basal cell carcinoma area scalp ) diagnose less 5 year prior screen . Subjects cancer full remission 5 year diagnosis acceptable . 13 . Alcohol abuse drug abuse within past 6 month 14 . Consumption great 2 standard alcoholic drink per day 15 . Use medicinal marijuana 16 . Participation clinical research trial within 30 day prior randomization 17 . Allergy sensitivity study product and/or 's ingredient 18 . Individuals cognitively impair and/or unable give inform consent 19 . Any condition Investigator 's opinion may adversely affect subject 's ability complete study measure may pose significant risk subject ( e.g . cardiovascular , renal , lung , diabetes , psychiatric illness , bleed disorder etc )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>